Discovery of genetic suppressor mutations that rescue frataxin deficiency

Frataxin is essential for making mitochondrial iron-sulfur clusters, which are critical cofactors for many enzymes. Loss of frataxin normally causes severe cellular dysfunction, but studies in yeast, worms, mice, and human cells show that low oxygen (hypoxia) can partially rescue this defect. Remarkably, nematodes completely lacking frataxin survive in hypoxia and still make iron-sulfur clusters. Using this oxygen-sensitive model, researchers screened for second-site mutations that allow survival even at normal oxygen levels. These mutations act as genetic modifiers, bypassing the need for frataxin. Dr. Meisel aims to uncover the molecular mechanisms behind this rescue—identifying the genes and pathways that compensate for frataxin loss. Understanding these mechanisms could reveal new therapeutic strategies for FA.